ARCHIVES

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

This article is from The Cancer Letter archive.

Vol. 08 No. 27 | July 2, 1982

Download PDF Visit The Full Archive

Related Articles

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991